A. Jans Pharma SRL
A. Jans Pharma reported total assets of €1.03m at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
The score of A. Jans Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +144 % Total assets -23 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
A. Jans Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
A. Jans Pharma's financial analysis
- Solvency89.8%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of A. Jans Pharma
A. Jans Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0754.509.847
- VAT number
- BE0754509847
- Peppol
- Registered · 0208:0754509847 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Sep 2020
- Registered office
- 3960 Bree
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
A. Jans Pharma (SRL) has been based in Bree since 2020, active in: activities of holding companies. For 2025, it reports a net profit of 70,324 € and equity of 926,036 €; its revenue is not published. Its solvency stands at 89.8%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to A. Jans Pharma
Companies in the same business, of comparable size and area, outside its group.
- Saltho Activities of holding companies Wavre · balance sheet €1.03m
- Marpa Patrimoine Activities of holding companies Herve · balance sheet €1.03m
- Almapro Activities of holding companies Ternat · balance sheet €1.03m
- Colormatics Holding Activities of holding companies Lanaken · balance sheet €1.03m
- Vamalya Activities of holding companies Philippeville · balance sheet €1.03m
- Juna Holding Activities of holding companies Leopoldsburg · balance sheet €1.03m
- Rostekop Activities of holding companies Ghent · balance sheet €1.03m
- Collignon Management Activities of holding companies Érezée · balance sheet €1.03m
Frequently asked questions about A. Jans Pharma
What is the revenue of A. Jans Pharma?
A. Jans Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of A. Jans Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0754509847 for A. Jans Pharma, if the company is VAT-registered. Its company number (CBE) is 0754.509.847.
Where is the registered office of A. Jans Pharma?
According to the CBE register, the registered office of A. Jans Pharma is in 3960 Bree.
What is the equity of A. Jans Pharma?
At the close of the 2025 financial year, the equity of A. Jans Pharma amounts to 926,036 €, a solvency of 89.8% of total assets.
Who manages A. Jans Pharma?
The register lists 1 active mandates at A. Jans Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of A. Jans Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →